Advertisement

Topics

Cambridge's Exonics Therapeutics Scores $40M

19:00 EST 7 Nov 2017 | BioSpace

Funds to support continued development of SingleCut CRISPR technology for Duchenne muscular dystrophy.

Original Article: Cambridge's Exonics Therapeutics Scores $40M

NEXT ARTICLE

More From BioPortfolio on "Cambridge's Exonics Therapeutics Scores $40M"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Muscular Dystrophy
Muscular dystrophy is a group of degenerative inherited disorders causing muscle weakness and loss of muscle tissue. The different types are Becker muscular dystrophy, Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, Facioscapulohumeral mu...